Effects of mometasone furoate dry powder inhaler and beclomethasone dipropionate hydrofluoroalkane and chlorofluorocarbon on the hypothalamic-pituitary-adrenal axis in asthmatic subjects

被引:32
作者
Chrousos, GP [1 ]
Ghaly, L
Shedden, A
Iezzoni, DG
Harris, AG
机构
[1] Univ Athens, Sch Med, Dept Pediat 1, Aghia Sophia Childrens Hosp, GR-11527 Athens, Greece
[2] Integrated Therapeut Grp, Kenilworth, NJ USA
关键词
asthma; beclomethasone dipropionate; corticosteroid; hypothalamo-hypophyseal system; mometasone furoate;
D O I
10.1378/chest.128.1.70
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Study objectives: Mometasone furoate dry powder inhaler (MF-DPI) [400 mu g] is an inhaled corticosteroid (ICS) that is effective in the treatment of asthma. MF-DPl has a low potential for suppression of the hypothalamic-pituitary-adrenal (HPA) axis at its clinical dose. The effect of MF-DPI, 400 mu g qd, on the UPA axis was compared to that of beclomethasone dipropionate (BDP) using hydrofluoroalkane, (HFA) and chlorofluorocarbon (CFC) propellants via metered-dose inhalers (MDIs) twice daily. Design and interventions: This randomized, third-party blind, parallel-group study compared the effects of MF-DPl 400 mu g one puff qd in the morning (n 18), HFA-BDP 200 mu g two puffs MDI bid (n = 18), and CFC-BDP 400 mu g two puffs MDI bid (n 17) for 14 days on the area under the 24-h serum cortisol concentrations curve (AUC(0-24)) and on total 24-h urinary free cortisol excretion in mild asthmatic subjects. Effects on morning/evening peak expiratory How (PEF) and on inhaled albuterol use were also assessed. Adverse events that occurred during or >= 30 days after the study were recorded. Results: The mean decrease from baseline in the serum cortisol concentrations AUC(0-24) in the MF-DPI group was significantly less than in either the HFA-BDP (p = 0.024) or the CFC-BDP (p = 0.011) groups. Decreases in serum cortisol concentrations AUC(0-24) in the two BDP groups did not differ from one another. The MF-DPI group trended toward higher morning and evening PEF than either BDP group. Treatment-associated adverse events were reported by seven subjects in the MF-DP1 group, vs one subject in the HFA-BDP and three subjects in the CFC-BDP groups; these were mild, and no subject discontinued treatment due to an adverse event. Conclusions: Fourteen days of treatment with MF-DP1 400 mu g qd was associated with a significantly lesser decrease in the serum cortisol concentrations AUC(0-24) compared With HFA-BDP 200 mu g MDI or CFC-BDP 400 mu g MDI bid.
引用
收藏
页码:70 / 77
页数:8
相关论文
共 27 条
  • [1] Mometasone furoate has minimal effects on the hypothalamic-pituitary-adrenal axis when delivered at high doses
    Affrime, MB
    Kosoglou, T
    Thonoor, CM
    Flannery, BE
    Herron, JM
    CHEST, 2000, 118 (06) : 1538 - 1546
  • [2] Hypothalamic-Pituitary-Adrenal Axis Effects of Mometasone Furoate/Formoterol Fumarate vs Fluticasone Propionate/Salmeterol Administered Through Metered-Dose Inhaler
    Kosoglou, Teddy
    Hubbell, James
    Cutler, David L.
    Johnson-Levonas, Amy O.
    Xu, Danlin
    Kantesaria, Bhavna S.
    Kim, Kenneth
    Miller, S. David
    CHEST, 2013, 144 (06) : 1795 - 1802
  • [3] Long-term safety of Mometasone Furoate administered via a dry powder inhaler in children: Results of an open-label study comparing Mometasone Furoate with Beclomethasone Dipropionate in children with persistent asthma
    Michael Noonan
    Jeffrey Leflein
    Jonathan Corren
    Heribert Staudinger
    BMC Pediatrics, 9
  • [4] Hypothalamic-Pituitary-Adrenal Axis Suppression in Asthmatic School Children
    Zoellner, Ekkehard Werner
    Lombard, Carl J.
    Galal, Ushma
    Hough, F. Stephen
    Irusen, Elvis M.
    Weinberg, Eugene
    PEDIATRICS, 2012, 130 (06) : E1512 - E1519
  • [5] Effects of intranasal corticosteroids on the hypothalamic-pituitary-adrenal axis in children
    Boner, AL
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 108 (01) : S32 - S39
  • [6] Influence of Long-Term Inhalation of Beclomethasone Dipropionate on Pituitary-Adrenal Axis Function in Asthmatic Children
    YAO Ze Zhong GU Yong LI Zhi JunDepartment of Pediatrics Taizhou Hospital Linhai Zhejiang China
    中国当代儿科杂志, 2002, (04) : 348 - 350
  • [7] Airway Inflammation and Hypothalamic-Pituitary-Adrenal Axis Activity in Asthmatic Adults with Depression
    Du, Yi-Jie
    Li, Bei
    Zhang, Hong-Ying
    Cao, Yu-Xue
    Duan, Xiao-Hong
    Gong, Wei-Yi
    Dong, Jing-Cheng
    JOURNAL OF ASTHMA, 2013, 50 (03) : 274 - 281
  • [8] Diurnal effects of fluoxetine and naloxone on the human hypothalamic-pituitary-adrenal axis
    Torpy, DJ
    Grice, JE
    Hockings, GI
    Walters, MM
    Crosbie, GV
    Jackson, RV
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1997, 24 (06) : 421 - 423
  • [9] Hypothalamic-pituitary-adrenal axis suppression in asthmatic children on inhaled and nasal corticosteroids - more common than expected ?
    Zoellner, Ekkehard Werner
    Lombard, Carl
    Galal, Ushma
    Hough, Stephen
    Irusen, Elvis
    Weinberg, Eugene
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2011, 24 (7-8) : 529 - 534
  • [10] Longitudinal hypothalamic-pituitary-adrenal axis trait and state effects in recurrent depression
    Lok, Anja
    Mocking, Roel J. T.
    Ruhe, Henricus G.
    Visser, Ieke
    Koeter, Maarten W. J.
    Assies, Johanna
    Bockting, Claudi L. H.
    Olff, Miranda
    Schene, Aart H.
    PSYCHONEUROENDOCRINOLOGY, 2012, 37 (07) : 892 - 902